The development of an electrochemical immunosensor utilizing chicken IgY anti-spike antibody for the detection of SARS-CoV-2

被引:10
|
作者
Al-Qaoud, Khaled M. [1 ]
Obeidat, Yusra M. [2 ]
Al-Omari, Tareq [1 ]
Okour, Mohammad [1 ]
Al-Omari, Mariam M. [3 ]
Ahmad, Mohammad I. [4 ,5 ,6 ]
Alshadfan, Raed [4 ,5 ]
Rawashdeh, AbdelMonem M. [7 ]
机构
[1] Yarmouk Univ, Fac Sci, Dept Biol Sci, Irbid, Jordan
[2] Yarmouk Univ, Hijjawi Fac Engn Technol, Dept Elect Engn, Irbid, Jordan
[3] Yarmouk Univ, Fac Med, Dept Basic Med Sci, Irbid, Jordan
[4] Rawgene Biotech, Umm Khelad St 33, Amman, Jordan
[5] Atlas Med, Sahab Ind Area, Amman, Jordan
[6] Univ Porto, Fac Pharm, Dept Chem Sci, Porto, Portugal
[7] Yarmouk Univ, Fac Sci, Dept Chem, Irbid, Jordan
关键词
D O I
10.1038/s41598-023-50501-w
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
This paper introduces a novel approach for detecting the SARS-CoV-2 recombinant spike protein combining a label free electrochemical impedimetric immunosensor with the use of purified chicken IgY antibodies. The sensor employs three electrodes and is functionalized with an anti-S IgY antibody, ELISA and immunoblot assays confirmed the positive response of chicken immunized with SARS-CoV2 S antigen. The developed immunosensor is effective in detecting SARS-CoV-2 in nasopharyngeal clinical samples from suspected cases. The key advantage of this biosensor is its remarkable sensitivity, and its capability of detecting very low concentrations of the target analyte, with a detection limit of 5.65 pg/mL. This attribute makes it highly suitable for practical point-of-care (POC) applications, particularly in low analyte count clinical scenarios, without requiring amplification. Furthermore, the biosensor has a wide dynamic range of detection, spanning from 11.56 to 740 ng/mL, which makes it applicable for sample analysis in a typical clinical setting.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] The development of an electrochemical immunosensor utilizing chicken IgY anti-spike antibody for the detection of SARS-CoV-2
    Khaled M. Al-Qaoud
    Yusra M. Obeidat
    Tareq Al-Omari
    Mohammad Okour
    Mariam M. Al-Omari
    Mohammad I. Ahmad
    Raed Alshadfan
    AbdelMonem M. Rawashdeh
    Scientific Reports, 14
  • [2] An update on the anti-spike monoclonal antibody pipeline for SARS-CoV-2
    Focosi, Daniele
    Franchini, Massimo
    Casadevall, Arturo
    Maggi, Fabrizio
    CLINICAL MICROBIOLOGY AND INFECTION, 2024, 30 (08) : 999 - 1006
  • [3] Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
    Jia Wei
    Philippa C. Matthews
    Nicole Stoesser
    Thomas Maddox
    Luke Lorenzi
    Ruth Studley
    John I. Bell
    John N. Newton
    Jeremy Farrar
    Ian Diamond
    Emma Rourke
    Alison Howarth
    Brian D. Marsden
    Sarah Hoosdally
    E. Yvonne Jones
    David I. Stuart
    Derrick W. Crook
    Tim E. A. Peto
    Koen B. Pouwels
    A. Sarah Walker
    David W. Eyre
    Nature Communications, 12
  • [4] Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
    Wei, Jia
    Matthews, Philippa C.
    Stoesser, Nicole
    Maddox, Thomas
    Lorenzi, Luke
    Studley, Ruth
    Bell, John I.
    Newton, John N.
    Farrar, Jeremy
    Diamond, Ian
    Rourke, Emma
    Howarth, Alison
    Marsden, Brian D.
    Hoosdally, Sarah
    Jones, E. Yvonne
    Stuart, David I.
    Crook, Derrick W.
    Peto, Tim E. A.
    Pouwels, Koen B.
    Walker, A. Sarah
    Eyre, David W.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [5] Towards an Electrochemical Immunosensor for the Detection of Antibodies against SARS-CoV-2 Spike Protein
    Liustrovaite, Viktorija
    Drobysh, Maryia
    Rucinskiene, Alma
    Baradoke, Ausra
    Ramanaviciene, Almira
    Plikusiene, Ieva
    Samukaite-Bubniene, Urte
    Viter, Roman
    Chen, Chien-Fu
    Ramanavicius, Arunas
    JOURNAL OF THE ELECTROCHEMICAL SOCIETY, 2022, 169 (03)
  • [6] Anti-spike protein antibody titer at the time of breakthrough infection of SARS-CoV-2 omicron
    Adachi, Eisuke
    Nagai, Etsuko
    Saito, Makoto
    Isobe, Masamichi
    Konuma, Takaaki
    Koga, Michiko
    Tsutsumi, Takeya
    Nannya, Yasuhito
    Yotsuyanagi, Hiroshi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (07) : 1015 - 1017
  • [7] Emerging anti-spike monoclonal antibodies against SARS-CoV-2
    Ordaya, Eloy E.
    Razonable, Raymund R.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (03) : 191 - 201
  • [8] Sensitive detection of anti-spike antibodies enables improved understanding of SARS-CoV-2 pathogenesis
    Milling, Simon
    IMMUNOLOGY, 2021, 164 (01) : 1 - 2
  • [9] Anti-spike antibody responses to SARS-CoV-2 mRNA vaccines in people with schizophrenia and schizoaffective disorder
    Nemani, Katlyn
    De Picker, Livia
    Dickerson, Faith
    Leboyer, Marion
    Santacatterina, Michele
    Ando, Fumika
    Capichioni, Gillian
    Smith, Thomas E.
    Kammer, Jamie
    El Abdellati, Kawtar
    Morrens, Manuel
    Coppens, Violette
    Katsafanas, Emily
    Origoni, Andrea
    Khan, Sabahat
    Rowe, Kelly
    Ziemann, R. Sarah
    Tamouza, Ryad
    Yolken, Robert H.
    Goff, Donald C.
    BRAIN BEHAVIOR & IMMUNITY-HEALTH, 2024, 38
  • [10] Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody
    Phan, Tin
    Zitzmann, Carolin
    Chew, Kara W.
    Smith, Davey M.
    Daar, Eric S.
    Wohl, David A.
    Eron, Joseph J.
    Currier, Judith S.
    Hughes, Michael D.
    Choudhary, Manish C.
    Deo, Rinki
    Li, Jonathan Z.
    Ribeiro, Ruy M.
    Ke, Ruian
    Perelson, Alan S.
    PLOS PATHOGENS, 2024, 20 (04)